ResearcherHerlev HospitalActive in the last 2 years

Laura Kofoed Kjær

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7389-7750; OpenAlex author ID A5075178587. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. Co-author DOI 10.1002/iid3.70545 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Inna M. Chen · 1 shared paper, 2026 · strength 0.33
- Paper Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. DOI 10.1002/iid3.70545 ↗
Susann Theile · 1 shared paper, 2026 · strength 0.33
- Paper Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. DOI 10.1002/iid3.70545 ↗
Mads Hald Andersen · 1 shared paper, 2026 · strength 0.33
- Paper Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. DOI 10.1002/iid3.70545 ↗
Julia Sidenius Johansen · 1 shared paper, 2026 · strength 0.33
- Paper Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. DOI 10.1002/iid3.70545 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.